VTCN1 and ovarian cancer: According to the TCGA ovarian serous cystadenocarcinoma dataset, the most robust B7H4 expression occurs in ovarian cancer’s immunoreactive/C2 and differentiated/C4 subsets, characterised by high T-cell infiltrations [113,114,115].